Managing Paraneoplastic Neurological Disorders

Managing Paraneoplastic Neurological Disorders Janet W. de Beukelaar, Peter A. Sillevis Smitt Oncologist 2006; 11: 292-305 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in the field of Neuro-Oncology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the autoimmune pathogenesis of paraneoplastic neurological syndromes. Explain the clinical value of paraneoplastic antibody detection. Describe the general treatment approach to paraneoplastic neurological syndromes. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Mar. 20, 2006 Most Recent Review: May 8, 2007* Most Recent Update: Mar. 20, 2006 Date Credit Expires: Mar. 20, 2008 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.